Evidence explainerWomen's Hair Loss
Minoxidil for Women: Topical Foam vs Low-Dose Pills, by the Trials
Topical minoxidil roughly doubled the odds of noticeable regrowth vs placebo in women. Low-dose oral minoxidil gave similar results in trials, with more unwanted hair growth, and it is off-label.
Key takeaways
- Pooled data from 6 trials: 157 of 593 women on topical minoxidil reported moderate to marked regrowth vs 77 of 555 on placebo (risk ratio 1.93) [1].
- Minoxidil 2% and 5% showed no difference in regrowth or side effects in women [1].
- Across 4 trials (279 people), oral and topical minoxidil gave similar hair density and diameter; oral minoxidil roughly doubled the risk of unwanted hair growth [2].
- In 1,404 people on low-dose oral minoxidil, unwanted hair growth affected 15.1%; lightheadedness 1.7% and fluid retention 1.3%, with no life-threatening effects reported [3].
Topical minoxidil
The 2016 Cochrane review included 47 trials in 5,290 women; 17 evaluated minoxidil [1]. Topical minoxidil increased the chance of moderate to marked regrowth by participant and investigator ratings, and total hair count rose by about 13 hairs per cm² vs placebo [1].
Four trials (1,006 women) compared 2% with 5% and found no difference in regrowth or adverse events [1]. The over-the-counter 5% foam for women is used once daily; the label says results may take 3 months, and some women need at least 6 months [4].
Low-dose oral minoxidil
A 2025 meta-analysis of 4 randomized trials in people with androgenetic alopecia (279 people, 24 to 39 weeks) found no difference between oral and topical minoxidil in hair density or diameter [2]. Unwanted hair growth (hypertrichosis) was about twice as common with the oral form, and low blood pressure did not differ significantly [2].
Oral minoxidil tablets are FDA-approved only for severe high blood pressure, so using them for hair loss is off-label and needs a prescriber [5].
Safety at hair-loss doses
In a retrospective multicenter study of 1,404 people (67% women), the most frequent side effect of low-dose oral minoxidil was unwanted hair growth (15.1%), and systemic effects such as lightheadedness, fluid retention and fast heartbeat each affected under 2% [3]. The study had no control group [3].
At blood pressure doses, minoxidil tablets carry a warning that they can cause pericardial effusion and worsen angina [5]. The topical label says to stop and ask a doctor if chest pain, a rapid heartbeat, faintness, dizziness, sudden weight gain or swelling of the hands or feet occurs [4].
Choosing between them
Trials show similar results, so the choice usually comes down to tolerance: scalp irritation or the routine of a daily topical vs unwanted hair growth and the need for a prescription with the pill [2][3][4]. For laser caps, spironolactone and supplements, see the women's hair loss hub.
Quick answers
More in Women's Hair Loss
References
- [1]Interventions for female pattern hair loss. Cochrane Database Syst Rev, 2016.
- [2]Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials. Int J Dermatol, 2025.
- [3]Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol, 2021.
- [4]Minoxidil for Women (minoxidil 5%) aerosol, foam: drug facts label. DailyMed, U.S. National Library of Medicine, 2026.
- [5]Minoxidil tablets: prescribing information. DailyMed, U.S. National Library of Medicine, 2026.
